ÂÜÀòÂÒÂ×

Jose Calle Gordo is a global medical device executive with over 30 years of business experience. Currently Jose Calle is a managing partner at Valiance Advisors, a venture growth investment firm in London, chairman at Highlife, a start up developing a trans-septal mitral replacement device and a board member in several medical device companies. Before that, he served as CEO and director of Biosensors International, where he lead the transformation and expansion of Biosensors from a start up to a recognized multi-national in Vascular Intervention. Previously he held several leadership roles at Abbott Vascular and Guidant in the fields of coronary intervention, structural heart, peripheral vascular and cardiac rhythm management, where he lead the team that developed and commercialized the Xience family of dug eluting stents. Jose started his career at Eli Lilly where he had a number of commercial roles with growing responsibility in the field of cardiac devices. Jose is a Spanish national and currently lives with his family in the UK. Jose Calle Gordo holds an electrical engineering degree (MSc) from the Universidad Politecnica de Madrid, Spain.